Results 261 to 270 of about 383,810 (341)
The purinergic signaling interfaces in breast cancer angiogenesis. [PDF]
da Silva FC +3 more
europepmc +1 more source
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong +6 more
wiley +1 more source
Histopathologic evidence of VEGF in early neovascular AMD: from a 1992 hypothesis to a 1994 discovery - a historical perspective. [PDF]
Dastgheib KA.
europepmc +1 more source
A Novel Endothelial Growth Factor VEGF and Its Receptor
Masabumi Shibuya
openalex +2 more sources
A post‐stroke perivascular niche of microglia characterized by low expression of M2 markers and elevated glycolysis, oxidative phosphorylation (OXPHOS), and phagocytic activity is identified, which is termed stroke‐activated vascular‐associated microglia (stroke‐VAM).
Yanan Li +8 more
wiley +1 more source
Impact of Antivascular Endothelial Growth Factor Therapy in Chronic Subdural Hematoma Patients: A Propensity-Matched Multi-Institutional Cohort Study. [PDF]
Costa M, O'Leary S, Young CC, Kan P.
europepmc +1 more source
This study provides the first evidence that PM2.5 impairs iWAT browning via PTG‐mediated glycogen metabolism disruption, which is initiated by ADRB3 inhibition and subsequently triggers VEGFB upregulation. It thereby delineates the ADRB3‐PTG‐VEGFB axis as central to PM2.5‐induced metabolic dysfunction and identifies adipose glycogen metabolism as a ...
Limin Wang +12 more
wiley +1 more source
Can the Spatial Heterogeneity in the Epiligament Explain the Differential Healing Capacities of the ACL and MCL? [PDF]
Gaydarski L +3 more
europepmc +1 more source

